These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 2285302)

  • 21. In-vitro susceptibility of cefoperazone-susceptible and -resistant gram-negative rods to cefoperazone plus sulbactam, other beta-lactams, aminoglycosides and quinolone.
    Chandrasekar PH; Sluchak JA
    Infection; 1991; 19(1):49-53. PubMed ID: 2013510
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Efficacy of oxacillin and ampicillin-sulbactam combination in experimental endocarditis caused by beta-lactamase-hyperproducing Staphylococcus aureus.
    Thauvin-Eliopoulos C; Rice LB; Eliopoulos GM; Moellering RC
    Antimicrob Agents Chemother; 1990 May; 34(5):728-32. PubMed ID: 2360813
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Epigallocatechin gallate synergy with ampicillin/sulbactam against 28 clinical isolates of methicillin-resistant Staphylococcus aureus.
    Hu ZQ; Zhao WH; Hara Y; Shimamura T
    J Antimicrob Chemother; 2001 Sep; 48(3):361-4. PubMed ID: 11533000
    [TBL] [Abstract][Full Text] [Related]  

  • 24. In vitro comparison of cefoperazone/sulbactam with selected antimicrobials against 300 bacteroides isolates. Inhibitory activity and time-kill kinetic studies.
    Gelfand MS; Grogan JT; Haas MJ
    Diagn Microbiol Infect Dis; 1989; 12(5):421-8. PubMed ID: 2612130
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Multicentre study on antibiotic susceptibilities of anaerobic bacteria to cefoperazone-sulbactam and other antimicrobial agents.
    Clark RB; Bartelt MA; Chan EL; Dalton HP
    J Antimicrob Chemother; 1992 Jan; 29(1):57-67. PubMed ID: 1737725
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Activity of sulbactam combinations against Escherichia coli isolates with known amounts of TEM-1 beta-lactamase.
    Livermore DM
    J Antimicrob Chemother; 1992 Feb; 29(2):222-4. PubMed ID: 1506339
    [No Abstract]   [Full Text] [Related]  

  • 27. Activities of trovafloxacin and ampicillin-sulbactam alone or in combination versus three strains of vancomycin- intermediate Staphylococcus aureus in an in vitro pharmacodynamic infection model.
    Aeschlimann JR; Hershberger E; Rybak MJ
    Antimicrob Agents Chemother; 2000 May; 44(5):1153-8. PubMed ID: 10770744
    [TBL] [Abstract][Full Text] [Related]  

  • 28. In vitro activities of cefoperazone and sulbactam singly and in combination against cefoperazone-resistant members of the family Enterobacteriaceae and nonfermenters.
    Fass RJ; Gregory WW; D'Amato RF; Matsen JM; Wright DN; Young LS
    Antimicrob Agents Chemother; 1990 Nov; 34(11):2256-9. PubMed ID: 2073118
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Antibacterial activity of the sulbactam-ampicillin combination.
    Sessarego FV; Botta GA; Pesce A; Schito GC
    J Chemother; 1989 Dec; 1(6):384-7. PubMed ID: 2614505
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Error rates in cefoperazone and cefoperazone-sulbactam disk tests with Enterobacteriaceae and Pseudomonas aeruginosa.
    Hardy DJ; Barry AL; Fuchs PC; Gerlach EH; McLaughlin JC; Pfaller MA
    Eur J Clin Microbiol Infect Dis; 1992 Oct; 11(10):926-30. PubMed ID: 1486889
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Synergy of gatifloxacin with cefoperazone and cefoperazone-sulbactam against resistant strains of Pseudomonas aeruginosa.
    Sivagurunathan N; Krishnan S; Rao JV; Nagappa AN; Subrahmanyam VM; Vanathi BM
    J Med Microbiol; 2008 Dec; 57(Pt 12):1514-1517. PubMed ID: 19018022
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Efficacy of cefoperazone in combination with sulbactam in experimental Staphylococcus aureus endocarditis in rabbits.
    Chambers HF; Fournier MA
    J Antimicrob Chemother; 1993 Sep; 32(3):453-8. PubMed ID: 8262867
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Vancomycin and oxacillin synergy for methicillin-resistant staphylococci.
    Domaracki BE; Evans AM; Venezia RA
    Antimicrob Agents Chemother; 2000 May; 44(5):1394-6. PubMed ID: 10770789
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Resistance to cefoperazone-sulbactam in Klebsiella pneumoniae: evidence for enhanced resistance resulting from the coexistence of two different resistance mechanisms.
    Rice LB; Carias LL; Etter L; Shlaes DM
    Antimicrob Agents Chemother; 1993 May; 37(5):1061-4. PubMed ID: 8390809
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Susceptibilities of anaerobic gram-negative bacilli to thirteen antimicrobials and beta-lactamase inhibitor combinations.
    Hill GB; Ayers OM; Everett BQ
    J Antimicrob Chemother; 1991 Dec; 28(6):855-67. PubMed ID: 1816182
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Antimicrobial susceptibility of coagulase-negative staphylococci isolated from bovine mastitis in Argentina.
    Gentilini E; Denamiel G; Betancor A; Rebuelto M; Rodriguez Fermepin M; De Torrest RA
    J Dairy Sci; 2002 Aug; 85(8):1913-7. PubMed ID: 12214983
    [TBL] [Abstract][Full Text] [Related]  

  • 37. In vitro activity of minocycline alone and in combination with cefoperazone-sulbactam against carbapenem-resistant Acinetobacter baumannii.
    Pei G; Mao Y; Sun Y
    Microb Drug Resist; 2012 Dec; 18(6):574-7. PubMed ID: 22928863
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of different combinations of sparfloxacin, oxacillin, and fosfomycin against methicillin-resistant staphylococci.
    Ferrara A; Dos Santos C; Cimbro M; Gialdroni Grassi G
    Eur J Clin Microbiol Infect Dis; 1997 Jul; 16(7):535-7. PubMed ID: 9272391
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The cefoperazone-sulbactam combination. In vitro qualities including beta-lactamase stability, antimicrobial activity, and interpretive criteria for disk diffusion tests.
    Jones RN; Barry AL; Thornsberry C; Wilson HW
    Am J Clin Pathol; 1985 Oct; 84(4):496-504. PubMed ID: 2994461
    [TBL] [Abstract][Full Text] [Related]  

  • 40. In vitro antimicrobial spectrum, occurrence of synergy, and recommendations for dilution susceptibility testing concentrations of the cefoperazone-sulbactam combination.
    Jones RN; Barry AL; Packer RR; Gregory WW; Thornsberry C
    J Clin Microbiol; 1987 Sep; 25(9):1725-9. PubMed ID: 3498740
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.